- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 3 residues within 4Å:- Chain A: H.694, V.695, N.696
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 6 residues within 4Å:- Chain A: N.748, N.749, A.1117, P.1118, G.1170
- Chain B: D.835
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.748, A:N.749
NAG-NAG.6: 6 residues within 4Å:- Chain A: N.655, T.657, Q.683
- Chain B: A.885, R.886, D.887
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain B: T.147, T.148, N.273, T.275
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain B: N.748, I.1169, G.1170
- Chain C: D.835
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 7 residues within 4Å:- Chain A: Y.435, H.558
- Chain B: Q.154, E.171, N.204, C.205, T.206
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 7 residues within 4Å:- Chain B: N.161, A.162, T.163, N.164, V.166, V.210, P.213
No protein-ligand interaction detected (PLIP)NAG-NAG.24: 6 residues within 4Å:- Chain B: Y.528
- Chain C: G.378, E.379, N.382, S.410, S.412
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 5 residues within 4Å:- Chain A: D.835
- Chain C: N.748, N.749, I.1169, G.1170
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 4 residues within 4Å:- Chain C: K.152, E.171, N.203, N.204
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 5 residues within 4Å:- Chain C: T.147, T.148, N.273, T.275, R.276
No protein-ligand interaction detected (PLIP)NAG-NAG.29: 3 residues within 4Å:- Chain A: K.874
- Chain C: N.655, T.657
No protein-ligand interaction detected (PLIP)- 8 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 9 residues within 4Å:- Chain A: F.377, G.378, F.381, N.382, V.406, S.410, A.411, S.412, F.413
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:V.406, A:A.411, A:S.412
NAG-NAG-BMA.5: 7 residues within 4Å:- Chain A: R.367, P.369, N.370, P.618, Q.619, T.620, L.621
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Q.619, A:T.620
NAG-NAG-BMA.7: 7 residues within 4Å:- Chain A: T.755, N.756, T.758, L.961, N.964, Q.965, Q.1110
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.961, A:N.964, A:Q.965
- Hydrogen bonds: A:N.964
NAG-NAG-BMA.11: 3 residues within 4Å:- Chain A: I.1171, V.1172, N.1173
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 4 residues within 4Å:- Chain B: G.378, N.382, S.410, S.412
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 3 residues within 4Å:- Chain A: K.597
- Chain B: E.320, N.321
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.18: 5 residues within 4Å:- Chain B: N.655, T.657, E.658, Q.683
- Chain C: I.873
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.30: 7 residues within 4Å:- Chain C: T.755, N.756, T.758, L.961, N.964, Q.965, Q.1110
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.961
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.9: 8 residues within 4Å:- Chain A: A.745, S.750, N.1113, F.1114, T.1115, S.1136, N.1137
- Chain B: Q.934
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:T.1115, A:T.1115, A:S.1136
NAG-NAG-FUC.21: 6 residues within 4Å:- Chain B: S.743, V.744, A.745, S.750, N.1113
- Chain C: Q.934
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.1113
NAG-NAG-FUC.32: 6 residues within 4Å:- Chain A: Q.934
- Chain C: S.743, A.745, S.750, E.1111, N.1113
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.19: 5 residues within 4Å:- Chain B: N.756, L.961, N.964, Q.965, Q.1110
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.961
NAG-NAG-BMA-MAN.20: 4 residues within 4Å:- Chain B: N.840, S.842, Q.843, Q.974
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.31: 3 residues within 4Å:- Chain C: N.840, S.842, Q.843
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.33: 5 residues within 4Å:- Chain C: N.1137, G.1138, T.1139, H.1140, F.1142
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.36: 5 residues within 4Å:- Chain A: Y.67, N.69, F.98, S.99, N.100
Ligand excluded by PLIPNAG.37: 7 residues within 4Å:- Chain A: N.161, A.162, T.163, N.164, V.166, K.168, V.210
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: N.203, N.204
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain A: T.147, T.148, N.273, T.275
- Ligands: NAG.41
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: N.642, T.643
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain A: R.276
- Ligands: NAG.39
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.67, N.100
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain B: Y.183, K.186, N.187, N.188, M.192
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain B: N.370, I.371, T.372, Q.619, T.620
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.642
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain B: H.694, V.695, N.696
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: Y.67, F.98, N.100
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain C: Y.183, N.188, S.190, S.194, E.195
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain C: N.642
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: H.694, N.696
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: N.370, I.371
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure of SARS CoV-2 full-length spike protein, 1RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Singh, S. et al., Structure of SARS CoV-2 full-length spike protein, 1RBD-up conformation. To Be Published
- Release Date
- 2025-04-16
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C